Tarsa Therapeutics
Philadelphia, US
Biotech
Founders & leadership
DB
David BrandExecutive Officer, Director
RK
Richard KollenderDirector
ME
Martin EdwardsDirector
EB
Eric BednarskiDirector
GL
Gregory LumpkinExecutive Officer
DF
Derek FergusonDirector
LG
Lewis GeffenExecutive Officer
JT
James TananbaumDirector
Reported raises · per SEC filings
Form D private placements$549.9KraisedJul 2017 · 3 investors · Biotechnology
Rule 506(b)$1.6MraisedJan 2017 · 5 investors · Biotechnology
Rule 506(b)$1.3MraisedJul 2016 · 7 investors · Biotechnology
Rule 506(b)$2MraisedFeb 2016 · 7 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.